Detailed answers about INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED, including incorporation, status, business activity, and accounts information.
When was INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED founded?
INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED was officially incorporated on 17 January 2012 and is registered under company number 07913236. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED?
INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED do?
INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED operates in the following sector: 86210 - General medical practice activities. This provides insight into the company's primary business activity and industry focus.
What is INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED's registered address?
The registered office address of INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED is 1 WELBECK STREET, LONDON, ENGLAND, W1G 0AR. This is the official address filed with Companies House for legal and statutory correspondence.
Is INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED financially stable?
The most recent accounts for INTERNATIONAL CENTRE FOR HORMONE HEALTH LIMITED were made up to 31 March 2025, filed as MICRO ENTITY. Next accounts are due by 31 December 2026.